Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2019

01-11-2019 | Chickenpox | Clinical Practice: Clinical Image

Varicella Pneumonia in an Immunocompetent Adult

Authors: Reika Miyokawa, MD, Paul Aronowitz, MD

Published in: Journal of General Internal Medicine | Issue 11/2019

Login to get access

Excerpt

A previously healthy 37-year-old man presented with fever, nonproductive cough, and 2 days of diffuse rash that started on his chest. He denied dyspnea. He had never received the chickenpox vaccine. Physical examination revealed vesicular lesions of various stages on the trunk, neck (Image 1), head, and extremities. Chest radiograph revealed bilateral patchy opacities, and a CT scan of the chest (Image 2) showed diffuse ground-glass opacities. The patient was treated with intravenous acyclovir for severe chickenpox (varicella-zoster virus), which was subsequently confirmed on vesicular fluid PCR. Human immunodeficiency virus testing was negative. On hospital day two, he developed respiratory failure requiring mechanical ventilation for 5 days. He had a full recovery and was discharged with a 10-day course of oral acyclovir.
Literature
1.
go back to reference Alanezi M. Varicella pneumonia in adults: 13 years’ experience with review of literature. Ann Thorac Med. 2007; 2(4): 163–165.CrossRef Alanezi M. Varicella pneumonia in adults: 13 years’ experience with review of literature. Ann Thorac Med. 2007; 2(4): 163–165.CrossRef
2.
go back to reference Franquet T. Imaging of Pulmonary Viral Pneumonia. Radiology. 2011;260(1):18–39.CrossRef Franquet T. Imaging of Pulmonary Viral Pneumonia. Radiology. 2011;260(1):18–39.CrossRef
3.
go back to reference Mirouse A, Vignon P, Piron P, et al. Severe varicella-zoster virus pneumonia: a multicenter cohort study. Crit Care. 2017;21(1):137.CrossRef Mirouse A, Vignon P, Piron P, et al. Severe varicella-zoster virus pneumonia: a multicenter cohort study. Crit Care. 2017;21(1):137.CrossRef
Metadata
Title
Varicella Pneumonia in an Immunocompetent Adult
Authors
Reika Miyokawa, MD
Paul Aronowitz, MD
Publication date
01-11-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05330-x

Other articles of this Issue 11/2019

Journal of General Internal Medicine 11/2019 Go to the issue

Hearling Arts: Materia Medica

The Story

Exercise in Clinical Reasoning

A Stressful Situation

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.